ID

35880

Descrizione

Abnormal Post-partum Glucose Metabolism After Gestational Diabetes Diagnosed Before or After 24 Weeks of Gestation; ODM derived from: https://clinicaltrials.gov/show/NCT01839448

collegamento

https://clinicaltrials.gov/show/NCT01839448

Keywords

versioni (1)
  1. 31/03/19 31/03/19 -
Titolare del copyright

See clinicaltrials.gov

Caricato su

31 marzo 2019

DOI

Per favore, per richiedere un accesso.

Licenza

Creative Commons BY 4.0
Commenti del modello :

Puoi commentare il modello dati qui. Tramite i fumetti nei gruppi di articoli e articoli è possibile aggiungere commenti a quelli in modo specifico.

Torna ai commenti del modello
Commenti del gruppo di articoli per :

Commenti dell'articolo per :

Per scaricare i modelli di dati devi essere registrato. Per favore accesso o registrati GRATIS.

Eligibility Gestational Diabetes NCT01839448

Inglese

Eligibility Gestational Diabetes NCT01839448

1 moduli  
Inclusion Criteria
Descrizione

Inclusion Criteria

Alias
UMLS CUI
C1512693
the patient must have given her informed and signed consent
Descrizione

Informed Consent

Tipo di dati

boolean

Alias
UMLS CUI [1]
C0021430
the patient must be insured or beneficiary of a health insurance plan
Descrizione

Patient is insured Health insurance plan | Insurance Beneficiary Health insurance plan

Tipo di dati

boolean

Alias
UMLS CUI [1,1]
C1548651
UMLS CUI [1,2]
C0679933
UMLS CUI [2,1]
C3853043
UMLS CUI [2,2]
C0679933
the patient is available for 10 months of follow-up
Descrizione

Patient Available Follow-up

Tipo di dati

boolean

Alias
UMLS CUI [1,1]
C0030705
UMLS CUI [1,2]
C0470187
UMLS CUI [1,3]
C3274571
the patient is pregnant and consulting before 24 weeks of amenorrhea and has at least one of the following risk factors: age > 35 years; body mass index > 25; family history of type 2 diabetes; history of gestational diabetes; history of macrosomia.
Descrizione

Pregnancy | Consultation Before Amenorrhea | Risk factors Quantity | Age | Body mass index | Family history of diabetes mellitus type 2 | Gestational Diabetes | Macrosomia

Tipo di dati

boolean

Alias
UMLS CUI [1]
C0032961
UMLS CUI [2,1]
C0009818
UMLS CUI [2,2]
C0332152
UMLS CUI [2,3]
C0002453
UMLS CUI [3,1]
C0035648
UMLS CUI [3,2]
C1265611
UMLS CUI [4]
C0001779
UMLS CUI [5]
C1305855
UMLS CUI [6]
C2316287
UMLS CUI [7]
C0085207
UMLS CUI [8]
C0158915
the patient has a fasting blood glucose level >= 0.92 g/l before 24 weeks of amenorrhea or a fasting blood glucose level < 0.92 g/l before 24 weeks of amenorrhea and an abnormal oral glucose tolerance test (75 g of glucose) between 24 and 28 weeks of amenorrhea (normal values are set at t0 < 0.92 g/l; t60 < 1.80 g/l; t120 < 1.53 g/l).
Descrizione

Fasting blood glucose measurement | Status pre- Amenorrhea | Oral Glucose Tolerance Test Abnormal

Tipo di dati

boolean

Alias
UMLS CUI [1]
C0428568
UMLS CUI [2,1]
C0332152
UMLS CUI [2,2]
C0002453
UMLS CUI [3,1]
C0029161
UMLS CUI [3,2]
C0205161
Exclusion Criteria
Descrizione

Exclusion Criteria

Alias
UMLS CUI
C0680251
the patient is participating in another study
Descrizione

Study Subject Participation Status

Tipo di dati

boolean

Alias
UMLS CUI [1]
C2348568
the patient is in an exclusion period determined by a previous study
Descrizione

Study Subject Participation Status | Exclusion Period

Tipo di dati

boolean

Alias
UMLS CUI [1]
C2348568
UMLS CUI [2,1]
C2828389
UMLS CUI [2,2]
C1948053
the patient is under judicial protection, under tutorship or curatorship
Descrizione

Guardianship

Tipo di dati

boolean

Alias
UMLS CUI [1]
C0870627
the patient refuses to sign the consent
Descrizione

Informed Consent Refused

Tipo di dati

boolean

Alias
UMLS CUI [1,1]
C0021430
UMLS CUI [1,2]
C1705116
it is impossible to correctly inform the patient
Descrizione

Patient Information Unsuccessful

Tipo di dati

boolean

Alias
UMLS CUI [1,1]
C1955348
UMLS CUI [1,2]
C1272705
the patient cannot read french
Descrizione

Lacking Able to read French language

Tipo di dati

boolean

Alias
UMLS CUI [1,1]
C0332268
UMLS CUI [1,2]
C0586740
UMLS CUI [1,3]
C0376246
the patient has a known history of type 2 diabetes
Descrizione

Diabetes Mellitus, Non-Insulin-Dependent

Tipo di dati

boolean

Alias
UMLS CUI [1]
C0011860
the patient is diagnosed with type 2 diabetes during pregnancy (fasting blood glucose level > 1.26 g/l)
Descrizione

Non-Insulin-Dependent Diabetes Mellitus During Pregnancy | Fasting blood glucose measurement

Tipo di dati

boolean

Alias
UMLS CUI [1,1]
C0011860
UMLS CUI [1,2]
C0347984
UMLS CUI [1,3]
C0032961
UMLS CUI [2]
C0428568
the patient has a contra-indication for a treatment necessary for this study
Descrizione

Medical contraindication Investigational Therapy

Tipo di dati

boolean

Alias
UMLS CUI [1,1]
C1301624
UMLS CUI [1,2]
C0949266
the patient is taking chronic or intermittent oral or inhaled corticosteroids, or a
Descrizione

Adrenal Cortex Hormones Oral chronic | Adrenal Cortex Hormones Oral Intermittent | Adrenal Cortex Hormones by Inhalation chronic | Adrenal Cortex Hormones by Inhalation Intermittent

Tipo di dati

boolean

Alias
UMLS CUI [1,1]
C0001617
UMLS CUI [1,2]
C1527415
UMLS CUI [1,3]
C0205191
UMLS CUI [2,1]
C0001617
UMLS CUI [2,2]
C1527415
UMLS CUI [2,3]
C0205267
UMLS CUI [3,1]
C0001617
UMLS CUI [3,2]
C0205535
UMLS CUI [3,3]
C0205191
UMLS CUI [4,1]
C0001617
UMLS CUI [4,2]
C0205535
UMLS CUI [4,3]
C0205267
β2 agonist treatment for a previous disease or a disease discovered during pregnancy within one week preceding the fasting glucose or oral glucose tolerance test.
Descrizione

Agonist Disease Previous | Disease Newly Diagnosed During Pregnancy | Glucose measurement, fasting | Oral Glucose Tolerance Test

Tipo di dati

boolean

Alias
UMLS CUI [1,1]
C2987634
UMLS CUI [1,2]
C0012634
UMLS CUI [1,3]
C0205156
UMLS CUI [2,1]
C0012634
UMLS CUI [2,2]
C1518321
UMLS CUI [2,3]
C0347984
UMLS CUI [2,4]
C0032961
UMLS CUI [3]
C0202045
UMLS CUI [4]
C0029161
Ritorna all'inizio della pagina

Similar models

Eligibility Gestational Diabetes NCT01839448

1 moduli
Name
genere
Description | Question | Decode (Coded Value)
Tipo di dati
Alias
Item Group
C1512693 (UMLS CUI)
Informed Consent
Item
the patient must have given her informed and signed consent
boolean
C0021430 (UMLS CUI [1])
Patient is insured Health insurance plan | Insurance Beneficiary Health insurance plan
Item
the patient must be insured or beneficiary of a health insurance plan
boolean
C1548651 (UMLS CUI [1,1])
C0679933 (UMLS CUI [1,2])
C3853043 (UMLS CUI [2,1])
C0679933 (UMLS CUI [2,2])
Patient Available Follow-up
Item
the patient is available for 10 months of follow-up
boolean
C0030705 (UMLS CUI [1,1])
C0470187 (UMLS CUI [1,2])
C3274571 (UMLS CUI [1,3])
Pregnancy | Consultation Before Amenorrhea | Risk factors Quantity | Age | Body mass index | Family history of diabetes mellitus type 2 | Gestational Diabetes | Macrosomia
Item
the patient is pregnant and consulting before 24 weeks of amenorrhea and has at least one of the following risk factors: age > 35 years; body mass index > 25; family history of type 2 diabetes; history of gestational diabetes; history of macrosomia.
boolean
C0032961 (UMLS CUI [1])
C0009818 (UMLS CUI [2,1])
C0332152 (UMLS CUI [2,2])
C0002453 (UMLS CUI [2,3])
C0035648 (UMLS CUI [3,1])
C1265611 (UMLS CUI [3,2])
C0001779 (UMLS CUI [4])
C1305855 (UMLS CUI [5])
C2316287 (UMLS CUI [6])
C0085207 (UMLS CUI [7])
C0158915 (UMLS CUI [8])
Fasting blood glucose measurement | Status pre- Amenorrhea | Oral Glucose Tolerance Test Abnormal
Item
the patient has a fasting blood glucose level >= 0.92 g/l before 24 weeks of amenorrhea or a fasting blood glucose level < 0.92 g/l before 24 weeks of amenorrhea and an abnormal oral glucose tolerance test (75 g of glucose) between 24 and 28 weeks of amenorrhea (normal values are set at t0 < 0.92 g/l; t60 < 1.80 g/l; t120 < 1.53 g/l).
boolean
C0428568 (UMLS CUI [1])
C0332152 (UMLS CUI [2,1])
C0002453 (UMLS CUI [2,2])
C0029161 (UMLS CUI [3,1])
C0205161 (UMLS CUI [3,2])
Item Group
C0680251 (UMLS CUI)
Study Subject Participation Status
Item
the patient is participating in another study
boolean
C2348568 (UMLS CUI [1])
Study Subject Participation Status | Exclusion Period
Item
the patient is in an exclusion period determined by a previous study
boolean
C2348568 (UMLS CUI [1])
C2828389 (UMLS CUI [2,1])
C1948053 (UMLS CUI [2,2])
Guardianship
Item
the patient is under judicial protection, under tutorship or curatorship
boolean
C0870627 (UMLS CUI [1])
Informed Consent Refused
Item
the patient refuses to sign the consent
boolean
C0021430 (UMLS CUI [1,1])
C1705116 (UMLS CUI [1,2])
Patient Information Unsuccessful
Item
it is impossible to correctly inform the patient
boolean
C1955348 (UMLS CUI [1,1])
C1272705 (UMLS CUI [1,2])
Lacking Able to read French language
Item
the patient cannot read french
boolean
C0332268 (UMLS CUI [1,1])
C0586740 (UMLS CUI [1,2])
C0376246 (UMLS CUI [1,3])
Diabetes Mellitus, Non-Insulin-Dependent
Item
the patient has a known history of type 2 diabetes
boolean
C0011860 (UMLS CUI [1])
Non-Insulin-Dependent Diabetes Mellitus During Pregnancy | Fasting blood glucose measurement
Item
the patient is diagnosed with type 2 diabetes during pregnancy (fasting blood glucose level > 1.26 g/l)
boolean
C0011860 (UMLS CUI [1,1])
C0347984 (UMLS CUI [1,2])
C0032961 (UMLS CUI [1,3])
C0428568 (UMLS CUI [2])
Medical contraindication Investigational Therapy
Item
the patient has a contra-indication for a treatment necessary for this study
boolean
C1301624 (UMLS CUI [1,1])
C0949266 (UMLS CUI [1,2])
Adrenal Cortex Hormones Oral chronic | Adrenal Cortex Hormones Oral Intermittent | Adrenal Cortex Hormones by Inhalation chronic | Adrenal Cortex Hormones by Inhalation Intermittent
Item
the patient is taking chronic or intermittent oral or inhaled corticosteroids, or a
boolean
C0001617 (UMLS CUI [1,1])
C1527415 (UMLS CUI [1,2])
C0205191 (UMLS CUI [1,3])
C0001617 (UMLS CUI [2,1])
C1527415 (UMLS CUI [2,2])
C0205267 (UMLS CUI [2,3])
C0001617 (UMLS CUI [3,1])
C0205535 (UMLS CUI [3,2])
C0205191 (UMLS CUI [3,3])
C0001617 (UMLS CUI [4,1])
C0205535 (UMLS CUI [4,2])
C0205267 (UMLS CUI [4,3])
Agonist Disease Previous | Disease Newly Diagnosed During Pregnancy | Glucose measurement, fasting | Oral Glucose Tolerance Test
Item
β2 agonist treatment for a previous disease or a disease discovered during pregnancy within one week preceding the fasting glucose or oral glucose tolerance test.
boolean
C2987634 (UMLS CUI [1,1])
C0012634 (UMLS CUI [1,2])
C0205156 (UMLS CUI [1,3])
C0012634 (UMLS CUI [2,1])
C1518321 (UMLS CUI [2,2])
C0347984 (UMLS CUI [2,3])
C0032961 (UMLS CUI [2,4])
C0202045 (UMLS CUI [3])
C0029161 (UMLS CUI [4])
Ritorna all'inizio della pagina 

Contatto

Si prega di utilizzare questo modulo per feedback, domande e suggerimenti per miglioramenti.

I campi contrassegnati da * sono obbligatori.

Aiuto

Do you need help on how to use the search function? Please watch the corresponding tutorial video for more details and learn how to use the search function most efficiently.

Watch Tutorial